None produce the dramatic results of semaglutide or tirzepatide, but several are considered safe during lactation and can produce meaningful weight loss
Cant wait to start seeing the results
This is an important consideration for future studies due to the larger effect size in risk of PDAC observed in patients with new onset compared with longstanding diabetes (typically defined as 3 years duration) 46
Obesity Overweight Gynaecological oncology This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial
This prevents beta-3 receptor desensitization while maintaining the appetite suppression and metabolic benefits of tirzepatide